Evidence map›Paper›PMID 41000140›Full record

ArticleCureus2025

Hemoglobin SC Sickle Cell Disease Presenting as Acute Ischemic Stroke With Moyamoya Syndrome in an Adult: A Case Report.

Tejashree Nidiginti, Basil Afzal, Reshmi Roy, Farhan Baig, Balwant Rai

Abstract readCase Reports
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Tejashree NidigintiGeneral Internal Medicine, Calderdale and Huddersfield NHS Foundation Trust, Halifax, GBR.
Basil AfzalGeneral Internal Medicine, Calderdale and Huddersfield NHS Foundation Trust, Halifax, GBR.
Reshmi RoyGeneral Internal Medicine, Calderdale and Huddersfield NHS Foundation Trust, Halifax, GBR.
Farhan BaigGeneral Internal Medicine, Calderdale and Huddersfield NHS Foundation Trust, Halifax, GBR.
Balwant RaiRadiology, Calderdale and Huddersfield NHS Foundation Trust, Huddersfield, GBR.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Moyamoya disease is a rare condition where blood vessels at the base of the brain become narrow or blocked. This leads to the growth of small, fragile vessels that look like a "puff of smoke" on imaging tests like CT or MRI scans. These vascular changes predominantly involve the terminal portion of the internal carotid arteries and the proximal segments of the anterior and middle cerebral arteries, leading to progressive stenosis and the development of collateral networks. Although the exact cause of moyamoya disease is unknown, it increases the risk of having a stroke. In this disease, there is partial or complete occlusion or narrowing in the terminal part of the carotid artery, seen in arterial imaging. When these intracerebral vessel changes happen along with other conditions, such as autoimmune diseases, vasculitis, hematological conditions like sickle cell anemia, renal problems like polycystic kidney disease, renal artery narrowing, and any metabolic causes, it is called moyamoya syndrome (MMS).  Our case report describes how we diagnosed and managed a 26-year-old male from Nigeria with MMS.

Indexed as

cerebrovascular diseasesmagnetic resonance angiography (mra)moyamoya disease and syndromeneuroimaging findingssickle cell disease (scd)stroketransient ischemic attacks

Identifiers

PMID41000140
PMCPMC12459641

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.